Market Size of Global Gastric Balloons Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 9.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gastric Balloons Market Analysis
The gastric balloon market is expected to register a CAGR of 9.5% over the forecast period.
The COVID-19 outbreak had a significant impact on the studied market as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. For instance, an article titled 'When Pandemics Collide: The Impact of COVID-19 on Childhood Obesity' published in February 2021 indicated that the disease of childhood obesity had risen to pandemic levels in United States youth with the fastest rise seen in severe obesity. The article also indicated that obese people were at risk for severe COVID-19, as excess weight decreases an individual's immune response. The increase in obesity cases during the COVID-19 pandemic is likely to enhance the market growth in the analysis period. Hence, COVID-19 had a pronounced impact on the studied market.
In addition, the rising prevalence of obesity and increasing demand for minimally invasive surgeries are actively affecting the growth of the studied market.
According to United Nations March 2022 article, more than one billion people worldwide are obese in 2022, including 650 million adults, 340 million adolescents, and 39 million children and the numbers are likely to rise. The World Health Organization predicted that by 2025, roughly 167 million people are projected to become less healthy due to being overweight or obese. Patients diagnosed with obesity and associated health risks such as diabetes and hypertension are given the option to undergo a gastric balloon procedure. The rising prevalence of obesity is the key driving factor in the gastric balloon market.
Furthermore, product approvals, launches, partnerships, and acquisitions are expected to propel market growth. For instance, in July 2020 Allurion Technologies expanded into the Asian market with the launch of the Elipse Gastric Balloon Weight Loss Program in Hong Kong, Malaysia, and Singapore. Over 1 billion overweight or obese people in the region were expected to benefit from the company's entry into Asia, a region that has previously had limited access to non-invasive weight loss treatments. Such initiatives are projected to further boost the market growth.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, poor reimbursement policies and side effects or complications associated with gastric balloons may impede the market growth.
